Congrats to @Aetioninc on their acquisition of @ReplicaAnalyti1, the pioneer of software to generate synthetic data. Proud to back this team as Aetion continues to advance the global impact of RWE. https://t.co/zoK5sKE7dy
Congratulations to the HilleVax team who is world class and hopefully bringing much-needed vaccine capabilities to the marketplace in short time!
https://t.co/sOxHxKMOsT
TIL in Finland they use to have about 4,000 reindeer/ car accidents a year so they paint their antlers with reflective paint and this is vaguely terrifying
Waiving IP has consequences... slippery slope... now they say “do insulin next”?
Let’s do PD1s after that because cancer is a global crisis...
Then let’s do Alzheimer’s..
Oh wait, we have no drugs for AD yet... and nor will we if there are no patents or reward for innovating
SF was always the Accidental Billionaire. Because of proximity to Silicon Valley, it benefitted from tech wealth its policies did nothing to create. Its collapse will redistribute opportunity to rest of country. So SF politicians will “spread the wealth” just not how they thought
Encouraging news today on Moderna vaccine. Technology will eventually let us greatly reduce the covid threat and reclaim normal times. Early data shows it generates robust immune reaction, and its dose dependent. Getting dose right is key. Moderna now testing a new 50mcg dose 1/x
Interesting data about global clinical trial enrollment and Covid-19's negative effect on it. Good news is that China enrollment has bounced back in Mar pointing to what other countries can face when turning the tide.
https://t.co/D3OVqCjogZ